2020 In Review: Despite Pandemic, The US FDA Issued Just 20% Fewer Drug GMP Warning Letters

2021 warning letter rate could decline further

 
• By Joanne S. Eglovitch
  
warning sign
Majority Of FDA's GMP Warning Letters Hit Domestic Firms Last Year
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance